lead has been researched along with Parasitemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calvet, CM; Choi, JY; de Mesquita, LB; de Souza Pereira, MC; Hirata, K; Lostracco-Johnson, S; McKerrow, JH; Meuser-Batista, M; Nogueira, A; Podust, LM; Roush, WR; Silva, TA; Siqueira-Neto, JL; Suzuki, B; Thomas, D | 1 |
Boini, KM; Föller, M; Huber, SM; Koka, S; Lang, C; Lang, F | 1 |
2 other study(ies) available for lead and Parasitemia
Article | Year |
---|---|
4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.
Topics: 14-alpha Demethylase Inhibitors; Animals; Chagas Disease; Disease Models, Animal; Drug Discovery; Female; Heart; Lead; Male; Mice; Mice, Inbred BALB C; Myocardium; Parasitemia; Pyrimidines; Sterol 14-Demethylase; Sterols; Trypanocidal Agents; Trypanosoma cruzi | 2017 |
Lead decreases parasitemia and enhances survival of Plasmodium berghei-infected mice.
Topics: Animals; Dose-Response Relationship, Drug; Erythrocyte Count; Erythrocytes; Flow Cytometry; Humans; Lead; Malaria; Mice; Nitrates; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Reticulocytes; Survival Analysis; Time Factors | 2007 |